CTA
EW icon

Carillon Tower Advisers’s Edwards Lifesciences EW Stock Holding History

Carillon Tower Advisers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$17.7M Sell
194,343
-18,897
-9% -$1.57M 0.11% 267
2020
Q3 		$17M Sell
213,240
-8,835
-4% -$689K 0.23% 170
2020
Q2 		$15.3M Hold
222,075
– – 0.12% 243
2020
Q1 		$14M Sell
222,075
-32,175
-13% -$2.32M 0.14% 227
2019
Q4 		$19.8M Buy
254,250
+58,950
+30% +$4.6M 0.13% 259
2019
Q3 		$14.3M Sell
195,300
-1,254,777
-87% -$88.1M 0.1% 291
2019
Q2 		$89.3M Sell
1,450,077
-47,400
-3% -$2.87M 0.61% 26
2019
Q1 		$95.5M Buy
1,497,477
+127,125
+9% +$7.25M 0.68% 19
2018
Q4 		$70M Sell
1,370,352
-199,245
-13% -$10.1M 0.59% 34
2018
Q3 		$91.1M Sell
1,569,597
-92,850
-6% -$4.54M 0.65% 24
2018
Q2 		$80.7M Buy
1,662,447
+547,806
+49% +$25.6M 0.64% 23
2018
Q1 		$50.3M Buy
1,114,641
+121,809
+12% +$5.29M 0.39% 75
2017
Q4 		$37.3M Buy
+992,832
New +$36.4M 0.4% 90

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Carillon Tower Advisers's EW Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Edwards Lifesciences (EW) stake by 8.9% in Q4 2020, selling an estimated $1.57M and leaving 194,343 shares worth $17.7M. The position accounts for 0.11% of the portfolio, ranked #267.

Carillon Tower Advisers first reported a position in EW in Q4 2017 and has held it in 13 quarters since. The position peaked at $95.5M in Q1 2019. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Carillon Tower Advisers held 194,343 shares of Edwards Lifesciences worth $17.7M as of Q4 2020.
  • Carillon Tower Advisers sold 18,897 Edwards Lifesciences shares in Q4 2020, an estimated $1.57M.
  • Edwards Lifesciences made up 0.11% of Carillon Tower Advisers's portfolio in Q4 2020, its #267 holding.
  • Carillon Tower Advisers first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 13 quarters since.
  • Carillon Tower Advisers's Edwards Lifesciences position peaked at $95.5M in Q1 2019.
  • 1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.